Izquierdo Roberto, Arekat Mona R, Knudson Paul E, Kartun Karen F, Khurana Kamal, Kort Kara, Numann Patricia J
Department of Medicine, SUNY Upstate Medical University, Syracuse, New York 13202, USA.
Endocr Pract. 2006 Nov-Dec;12(6):609-14. doi: 10.4158/EP.12.6.609.
To investigate the role of thyroid ultrasonography in our outpatient endocrine practice.
We compared the efficacy of ultrasound-guided fine-needle aspiration biopsy (US-FNAB) of thyroid nodules with that of palpation-guided aspiration (P-FNAB) and determined the malignancy rates of palpable and nonpalpable nodules. All patients referred for assessment of thyroid nodular disease from October 1997 through August 2001 were included in the study. Fine-needle aspirations were performed by palpation guidance until October 1999, after which US-FNAB was exclusively performed. All thyroid examinations, ultrasound imaging, and aspiration biopsies were performed by the same endocrinologist in an office-based setting. Histopathologic and cytologic diagnoses were compared for patients who underwent thyroidectomy.
A total of 376 nodules in 276 patients were aspirated during a 47-month period. P-FNAB was used on 157 nodules, and US-FNAB was performed on 219 nodules (both procedures were done on 21 nodules). For palpable thyroid nodules that were resected, the cytologic diagnostic accuracy rate was 60.9% and 80% for P-FNAB and US-FNAB, respectively. With use of ultrasound guidance, the sensitivity, positive predictive value, and negative predictive value increased significantly. In addition, the inadequate specimen rate decreased from 11.2% in the P-FNAB group to 7.1% in the US-FNAB group. Among the nodules that were not palpable, the malignancy rate was similar to that for the palpable thyroid nodules (5.1% versus 6.8%).
US-FNAB improved the cytologic diagnostic accuracy, sensitivity, and positive predictive value and reduced the false-negative rate in comparison with P-FNAB. The malignancy rate for nonpalpable thyroid nodules was similar to that for palpable nodules.
探讨甲状腺超声检查在我院门诊内分泌诊疗中的作用。
我们比较了甲状腺结节超声引导下细针穿刺活检(US-FNAB)与触诊引导下穿刺活检(P-FNAB)的效果,并确定了可触及结节与不可触及结节的恶性率。纳入了1997年10月至2001年8月间因甲状腺结节疾病前来评估的所有患者。1999年10月前采用触诊引导进行细针穿刺,之后仅采用US-FNAB。所有甲状腺检查、超声成像及穿刺活检均由同一位内分泌科医生在门诊进行。对接受甲状腺切除术的患者的组织病理学和细胞学诊断进行比较。
在47个月的时间里,共对276例患者的376个结节进行了穿刺。157个结节采用P-FNAB,219个结节采用US-FNAB(21个结节两种方法均采用)。对于已切除的可触及甲状腺结节,P-FNAB和US-FNAB的细胞学诊断准确率分别为60.9%和80%。采用超声引导后,敏感性、阳性预测值和阴性预测值均显著提高。此外,取材不足率从P-FNAB组的11.2%降至US-FNAB组的7.1%。在不可触及的结节中,恶性率与可触及甲状腺结节相似(5.1%对6.8%)。
与P-FNAB相比,US-FNAB提高了细胞学诊断的准确性、敏感性和阳性预测值,并降低了假阴性率。不可触及甲状腺结节的恶性率与可触及结节相似。